| Christopher Caracciolo, MD | |
|
133 Pleasant St, Berlin, NH 03570-2006 | |
| (603) 752-2040 | |
| Not Available |
| Full Name | Christopher Caracciolo |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 133 Pleasant St, Berlin, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073171435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | EC191058 (Maine) | Secondary |
| 207Q00000X | Family Medicine | MD24133 (Maine) | Secondary |
| 207Q00000X | Family Medicine | 23857 (New Hampshire) | Primary |
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467477349 PECOS PAC ID: 9335043967 Enrollment ID: O20031125000026 |
News Archive
Researchers at Case Western Reserve University School of Medicine and the Ireland Cancer Center of University Hospitals of Cleveland report identifying a new DNA gene marker, vimentin, that was shown in a recent study to be three times more effective in detecting colon cancer than the standard doctor's office test that detects blood in the stool.
Tests that analyze biomarkers are used during cancer management to guide treatment and provide information about patient prognosis.
Neuren Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) and authorised the Company to proceed with its Phase 3 trial to prevent cognitive impairment following major cardiac surgery using Glypromate.
Compounding pharmacies continue to face intense scrutiny over their drug preparation and lobbying habits after one in Massachusetts is suspected in distributing a steroid that led to a meningitis outbreak.
According to the National Cancer Institute, ovarian cancer causes more deaths than any other cancer of the female reproductive system. An estimated 20,180 new cases of ovarian cancer are expected in the United States this year.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Researchers at Case Western Reserve University School of Medicine and the Ireland Cancer Center of University Hospitals of Cleveland report identifying a new DNA gene marker, vimentin, that was shown in a recent study to be three times more effective in detecting colon cancer than the standard doctor's office test that detects blood in the stool.
Tests that analyze biomarkers are used during cancer management to guide treatment and provide information about patient prognosis.
Neuren Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) and authorised the Company to proceed with its Phase 3 trial to prevent cognitive impairment following major cardiac surgery using Glypromate.
Compounding pharmacies continue to face intense scrutiny over their drug preparation and lobbying habits after one in Massachusetts is suspected in distributing a steroid that led to a meningitis outbreak.
According to the National Cancer Institute, ovarian cancer causes more deaths than any other cancer of the female reproductive system. An estimated 20,180 new cases of ovarian cancer are expected in the United States this year.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Caracciolo, MD 133 Pleasant St, Berlin, NH 03570-2006 Ph: (603) 752-2040 | Christopher Caracciolo, MD 133 Pleasant St, Berlin, NH 03570-2006 Ph: (603) 752-2040 |
News Archive
Researchers at Case Western Reserve University School of Medicine and the Ireland Cancer Center of University Hospitals of Cleveland report identifying a new DNA gene marker, vimentin, that was shown in a recent study to be three times more effective in detecting colon cancer than the standard doctor's office test that detects blood in the stool.
Tests that analyze biomarkers are used during cancer management to guide treatment and provide information about patient prognosis.
Neuren Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) and authorised the Company to proceed with its Phase 3 trial to prevent cognitive impairment following major cardiac surgery using Glypromate.
Compounding pharmacies continue to face intense scrutiny over their drug preparation and lobbying habits after one in Massachusetts is suspected in distributing a steroid that led to a meningitis outbreak.
According to the National Cancer Institute, ovarian cancer causes more deaths than any other cancer of the female reproductive system. An estimated 20,180 new cases of ovarian cancer are expected in the United States this year.
› Verified 6 days ago
Alison Elizabeth Breault, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 133 Pleasant St, Berlin, NH 03570 Phone: 603-752-2040 | |
Neal David Keeshin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 59 Page Hill Rd, Berlin, NH 03570 Phone: 603-752-2200 Fax: 603-326-5999 | |
Dr. Javier De Jesus Cardenas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 Pleasant St, Berlin, NH 03570 Phone: 603-752-2040 Fax: 603-752-1709 | |
Apurva Bhatt, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 Pleasant St, Berlin, NH 03570 Phone: 603-752-2040 Fax: 603-752-7797 | |
Elaine Margaret Chappell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 Pleasant St, Berlin, NH 03570 Phone: 603-752-2040 Fax: 603-752-7797 | |
Dr. Michael Creppy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 Pleasant St, Berlin, NH 03570 Phone: 603-752-2040 Fax: 603-752-1709 |